Monarch Biosciences

About:

Monarch Biosciences is commercializing the next generation of cell therapy and regenerative medicine products.

Twitter/X: biomonarch

Top Investors: Checkmate Capital

Description:

MonarchBio is a Los Angeles-based biotechnology company focused on local delivery of cell therapies for treating solid tumors. MonarchBio's unique thin-film bio

Total Funding Amount:

$1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Los Angeles, California, United States

Founded Date:

2011-01-01

Founders:

Number of Employees:

11-50

Last Funding Date:

2020-04-08

IPO Status:

Private

Industries: